Our respiratory medicine group has the largest critical mass of respiratory researchers within the UK. There are two broad themes: respiratory infectious diseases and chronic lung disease.
Research programmes include investigating respiratory infections; tuberculosis; cell and leukocyte biology; airways and allergic diseases; integrative physiology and pharmacology; public health; and genetics and genomics. Our respiratory research groups have strong industry collaborations.
Our work spans fundamental discovery, translational and clinical studies undertaken in world-class research centres.
The Medical Research Council (MRC) Asthma UK Centre in Allergic Mechanisms of Asthma is a collaboration between Imperial and King’s College London (KCL) to advance the understanding of asthma at system, cellular and molecular levels, and to inform the development of new, effective and targeted treatments.
We also host the MRC Public Health England Centre for Environment and Health with KCL.
Our early phase clinical work is carried out at both our Brompton and St Mary’s campuses. In partnership with the Royal Brompton and Harefield NHS Foundation Trust, we host a National Institute of Health Research (NIHR) Respiratory Biomedical Research Unit which focuses on chronic lung disease; it's long term aim to increase the number of new therapeutic agents, devices or biomarkers entering phase I and II clinical trials. The Imperial Clinical Respiratory Research Unit was jointly established amby Imperial College Healthcare NHS Trust and the Centre for Respiratory Infection. The unit’s focus is on biomarkers for the measurement and profiling of inflammation, infection and repair.